P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura
Clinical trial NCT00603642 · COMPLETED
Trial details
- NCT number
- NCT00603642
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-04-13
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.